Rasagiline Mesylate Patent Expiration
Rasagiline Mesylate is Used for managing the symptoms of Parkinson's disease. It was first introduced by Teva Neuroscience Inc
Rasagiline Mesylate Patents
Given below is the list of patents protecting Rasagiline Mesylate, along with the drug name that holds that patent and the company name owning that drug.
| Drug Used in | Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Drug Owner |
|---|---|---|---|---|
| Azilect | US7815942 | Rasagiline formulations of improved content uniformity | Aug 27, 2027 | Teva |
| Azilect | US7572834 | Rasagiline formulations and processes for their preparation | Dec 05, 2026 | Teva |
| Azilect | US5453446 | Use of the R-enantiomers of N-propargyl 1-aminoindan compounds for treating Parkinson's disease. |
Feb 07, 2017
(Expired) | Teva |
| Azilect | US6126968 | Stable compositions containing N-propargyl-1-aminoindan |
Sep 18, 2016
(Expired) | Teva |
| Azilect | US5532415 | R-enantiomer of N-propargyl-1-aminoindan, salts, compositions and uses thereof |
Jul 02, 2013
(Expired) | Teva |
Rasagiline Mesylate's Family Patents
Explore Our Curated Drug Screens
Rasagiline Mesylate Generic API Manufacturers
Several generic applications have been filed for Rasagiline Mesylate. The first generic version for Rasagiline Mesylate was by Watson Laboratories Inc and was approved on Jul 1, 2013. And the latest generic version is by Macleods Pharmaceuticals Ltd and was approved on Jun 28, 2024.
Given below is the list of companies who have filed for Rasagiline Mesylate generic, along with the locations of their manufacturing plants worldwide.
1. ALKEM LABS LTD
Alkem Laboratories Ltd has filed for 2 different strengths of generic version for Rasagiline Mesylate. Given below are the details of the strengths of this generic introduced by Alkem Labs Ltd.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| EQ 0.5MG BASE | tablet | Prescription | ORAL | AB | Oct 30, 2017 |
| EQ 1MG BASE | tablet | Prescription | ORAL | AB | Oct 30, 2017 |
2. APOTEX INC
Apotex Inc has filed for 2 different strengths of generic version for Rasagiline Mesylate. Given below are the details of the strengths of this generic introduced by Apotex Inc.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| EQ 0.5MG BASE | tablet | Discontinued | ORAL | N/A | Sep 12, 2013 |
| EQ 1MG BASE | tablet | Discontinued | ORAL | N/A | Sep 12, 2013 |
Manufacturing Plant Locations New
Apotex Inc's manufacturing plants are situated in 1 country - Canada. Given below are the details of these plant locations as well as the firm names of Apotex Inc as present at those locations.
| Country | City | Firm Name | ||||||
|---|---|---|---|---|---|---|---|---|
| Canada |
| |||||||
3. AUROBINDO PHARMA USA
Aurobindo Pharma Usa Inc has filed for 2 different strengths of generic version for Rasagiline Mesylate. Given below are the details of the strengths of this generic introduced by Aurobindo Pharma Usa.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| EQ 0.5MG BASE | tablet | Prescription | ORAL | AB | May 15, 2017 |
| EQ 1MG BASE | tablet | Prescription | ORAL | AB | May 15, 2017 |
Manufacturing Plant Locations New
Aurobindo Pharma Usa's manufacturing plants are situated in 1 country - United States. Given below are the details of these plant locations as well as the firm names of Aurobindo Pharma Usa as present at those locations.
| Country | City | Firm Name | ||
|---|---|---|---|---|
| United States |
| |||
4. CHARTWELL RX
Chartwell Rx Sciences Llc has filed for 2 different strengths of generic version for Rasagiline Mesylate. Given below are the details of the strengths of this generic introduced by Chartwell Rx.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| EQ 0.5MG BASE | tablet | Prescription | ORAL | AB | Jul 27, 2018 |
| EQ 1MG BASE | tablet | Prescription | ORAL | AB | Jul 27, 2018 |
5. INDOCO
Indoco Remedies Ltd has filed for 2 different strengths of generic version for Rasagiline Mesylate. Given below are the details of the strengths of this generic introduced by Indoco.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| EQ 0.5MG BASE | tablet | Prescription | ORAL | AB | Oct 4, 2019 |
| EQ 1MG BASE | tablet | Prescription | ORAL | AB | Oct 4, 2019 |
Manufacturing Plant Locations New
Indoco's manufacturing plants are situated in 1 country - India. Given below are the details of these plant locations as well as the firm names of Indoco as present at those locations.
| Country | City | Firm Name | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| India |
| |||||||||
6. MACLEODS PHARMS LTD
Macleods Pharmaceuticals Ltd has filed for 2 different strengths of generic version for Rasagiline Mesylate. Given below are the details of the strengths of this generic introduced by Macleods Pharms Ltd.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| EQ 0.5MG BASE | tablet | Prescription | ORAL | AB | Jun 28, 2024 |
| EQ 1MG BASE | tablet | Prescription | ORAL | AB | Jun 28, 2024 |
7. MICRO LABS
Micro Labs Ltd has filed for 2 different strengths of generic version for Rasagiline Mesylate. Given below are the details of the strengths of this generic introduced by Micro Labs.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| EQ 0.5MG BASE | tablet | Prescription | ORAL | AB | Mar 29, 2019 |
| EQ 1MG BASE | tablet | Prescription | ORAL | AB | Mar 29, 2019 |
Manufacturing Plant Locations New
Micro Labs's manufacturing plants are situated in 1 country - India. Given below are the details of these plant locations as well as the firm names of Micro Labs as present at those locations.
| Country | City | Firm Name | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| India |
| |||||||||
8. ORBION PHARMS
Orbion Pharmaceuticals Private Ltd has filed for 2 different strengths of generic version for Rasagiline Mesylate. Given below are the details of the strengths of this generic introduced by Orbion Pharms.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| EQ 0.5MG BASE | tablet | Prescription | ORAL | AB | Mar 15, 2016 |
| EQ 1MG BASE | tablet | Prescription | ORAL | AB | Mar 15, 2016 |
9. RYAN LABS
Ryan Laboratories Llc has filed for 2 different strengths of generic version for Rasagiline Mesylate. Given below are the details of the strengths of this generic introduced by Ryan Labs.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| EQ 0.5MG BASE | tablet | Discontinued | ORAL | N/A | Nov 18, 2021 |
| EQ 1MG BASE | tablet | Discontinued | ORAL | N/A | Nov 18, 2021 |
10. SKG PHARMA
Skg Pharma Inc has filed for 2 different strengths of generic version for Rasagiline Mesylate. Given below are the details of the strengths of this generic introduced by Skg Pharma.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| EQ 1MG BASE | tablet | Prescription | ORAL | AB | Apr 9, 2024 |
| EQ 0.5MG BASE | tablet | Prescription | ORAL | AB | Apr 9, 2024 |
11. WATSON LABS INC
Watson Laboratories Inc has filed for 2 different strengths of generic version for Rasagiline Mesylate. Given below are the details of the strengths of this generic introduced by Watson Labs Inc.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| EQ 0.5MG BASE | tablet | Discontinued | ORAL | N/A | Jul 1, 2013 |
| EQ 1MG BASE | tablet | Discontinued | ORAL | N/A | Jul 1, 2013 |